The Society for Industrial Microbiology and Biotechnology will be hosting an open reception for SIMB members and scientists with similar interests on Monday July 15th, 5:30 – 8:00pm at CODA Brewing Company located at 15965 South Golden Road St. C2, Golden, CO 80401. This will be an opportunity to network with fellow scientists in a casual setting, hopefully leading to new collaborations and career opportunities.
This will also be an opportunity to will learn more about the benefits of membership in the Society, upcoming meetings, and opportunities to contribute to future meetings. Your hosts will be current SIMB Board of Director member Michael Resch (NREL) and SIMB President Elect Steve Decker (NREL).
This is a free event sponsored by SIMB and is open to Members and Non-Members.
So please, join us and raise a glass to celebrate yeast fermentation!
Celebrate DNA Day with Springer’s complimentary access to the Journal of Industrial Microbiology and Biotechnology (JIMB) special issue on “Natural Product Discovery and Development in the Genomic Era – 2019”
Access the special issue through May 15, 2019.
Congratulations to the winners for the 2019 Board of Directors election. The incoming officers are:
President-elect – Steve Decker, NREL
Director – Katy Kao, Texas A&M
Director – Priti Pharyka, Genomatica
Thanks to all who participated in the 2019 election.
The SIMB Election for positions on the Board of Directors will commence March 1, 2019. The election will end at noon ET on March 29, 2019 and members must join/renew by March 28, 2019 by noon ET to be eligible to vote. Current members for 2019 will receive login instructions by email. Member are to cast their vote here.
Results will be published on the SIMB website and in SIMB News.
**Student members are not eligible to vote.
Advances in Biopharmaceutical Technology in China, 2nd ed. is a peer-reviewed, ready reference for all aspects of biopharmaceuticals in China, including an understanding of the China biopharma current situation, and future opportunities. This is a must-read analysis of the state of biopharma in China.
The volume is published by BioPlan Associates, Inc., in cooperation with the Society for Industrial Microbiology and Biotechnology (SIMB). It provides a comprehensive overview of the biopharmaceutical industry, and the state of technology in China.
This reference’s 1,100+ pages of data-rich analysis and comprehensive assessment of China’s state-of-the-industry provides trends and analysis on the industry. It covers all types of organizations involved in biopharma in China, domestic, multinational, and government.